Gilead Sciences Inc Stock Ownership - Who owns Gilead Sciences?

Insider buying vs selling

Have Gilead Sciences Inc insiders been buying or selling?
Merdad ParseyChief Medical Officer2023-03-136,126$78.99
Johanna MercierChief Commercial Officer2023-03-105,116$79.50
Daniel Patrick OdayChairman CEO2023-03-1014,017$79.50
Andrew D. DickinsonChief Financial Officer2023-03-104,849$79.50
Merdad ParseyChief Medical Officer2023-03-105,328$79.50
Sandra PattersonSVP Controllership2023-03-10801$79.50
Kevin E. LoftonDirector2023-03-098,442$52.38
Daniel Patrick OdayChairman CEO2023-03-014,842$79.59
Merdad ParseyChief Medical Officer2023-03-0112,984$79.96
Merdad ParseyChief Medical Officer2023-02-15376$56.38

1 of 5

GILD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GILD insiders and whales buy or sell their stock.

GILD Shareholders

What type of owners hold Gilead Sciences Inc stock?
Blackrock Inc10.55%131,560,250$10.92BInstitution
Vanguard Group Inc8.98%112,038,324$9.30BInstitution
Capital World Investors5.52%68,892,972$5.72BInstitution
State Street Corp4.73%58,941,373$4.89BInstitution
Capital Research Global Investors4.38%54,602,952$4.53BInstitution
Dodge Cox2.88%35,885,152$2.98BInstitution
Geode Capital Management LLC1.91%23,848,477$1.98BInstitution
Morgan Stanley1.38%17,196,950$1.43BInstitution
Bank Of New York Mellon Corp1.33%16,545,609$1.37BInstitution
Fmr LLC1.32%16,438,903$1.36BInstitution

1 of 3

GILD vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GILD82.17%1.07%Net SellingNet Selling
AMGN76.52%0.99%Net SellingNet Selling
BMY76.07%0.34%Net SellingNet Selling

Gilead Sciences Stock Ownership FAQ

Who owns Gilead Sciences?

Gilead Sciences (NASDAQ: GILD) is owned by 82.17% institutional shareholders, 1.07% Gilead Sciences insiders, and 16.76% retail investors. Blackrock Inc is the largest individual Gilead Sciences shareholder, owning 131.56M shares representing 10.55% of the company. Blackrock Inc's Gilead Sciences shares are currently valued at $10.92B.

If you're new to stock investing, here's how to buy Gilead Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.